CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: Imbalance between NF-kappa B and STAT3 activation
S. Smola-hess et al., CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: Imbalance between NF-kappa B and STAT3 activation, EXP CELL RE, 267(2), 2001, pp. 205-215
Matrix-metalloproteinases (MMPs) are essentially required for tumor cell in
vasion and metastasis. Production of precursor enzymes is regulated on tran
scriptional level, while activation of the pro-enzymes is tightly controlle
d by posttranscriptional mechanisms. The enzyme activity can be blocked by
specific tissue inhibitors of MMPs (TIMPs). In cervical carcinomas strong u
p-regulation of the type IV collagenase MMP-9 had been demonstrated. We sho
w that activation of CD40, a receptor highly expressed on cervical carcinom
as, induces MMP-9 in cervical carcinoma cells, whereas TIMP-1 production in
hibiting MMP-9 activity was not affected. This gene induction pattern corre
sponded to the differential activation of the transcription factor nuclear
factor kappaB (NF-kappaB) regulating MMP-9, but not signal transducer and a
ctivator of transcription 3 (STAT3), which is involved in TIMP-1 gene regul
ation. Transient expression of the CD40-inducible NF-kappaB subunit p65 was
sufficient for MMP-9 induction. Agents that suppressed CD40-mediated NF-ka
ppaB activation also reduced MMP-9 induction, further supporting an importa
nt role of NF-kappaB in CD40-mediated MMP-9 induction, Our data suggest tha
t CD40 expression in carcinoma cells might convert a CD40L-dependent immuno
logical defense signal into a tumor-promoting signal. Selective CD40-mediat
ed signaling through NF-kappaB but not STAT3 correlates to a shift of the b
alance between MMP-9 and TIMP-1 toward the protease, (C) 2001 Academic Pres
s.